established — replicated in humans, or settled by a regulator
every claim resolves to its source
All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.
created page created as 'Vapreotide' with aliases RC-160, Sanvar, BMY 41606 · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
identity withheld identity not published: PubChem gave no record that proves it is this substance · 2026-09-27 04:00 · somebody
fact added summary: Vapreotide (RC-160) is a stable somatostatin analogue with moderate-to-high affinity for somatostatin receptor subtypes · 2026-09-27 04:00 · somebody
fact added history: In 227 patients with cirrhosis hospitalized for upper gastrointestinal bleeding, starting vapreotide before endoscopic t · 2026-09-27 04:00 · somebody
citation added pmid 7878022 cited as preclinical: RC-160 receptor subtype affinities and antiproliferative signalling · 2026-09-27 04:00 · somebody
citation added pmid 11136956 cited as established: Randomized trial of early vapreotide in variceal bleeding · 2026-09-27 04:00 · somebody
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.